Difference between revisions of "Periplakin"
m |
m |
||
| Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
! {{infobox header}}| '''{{PAGENAME}}''' | ! {{infobox header}}| '''{{PAGENAME}}''' | ||
| − | |||
| − | |||
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
Revision as of 13:58, 7 January 2008
| Template:Infobox header| Periplakin | |
|---|---|
| Substrate peptide name | Periplakin |
| Synonyms | 190 kDa paraneoplastic pemphigus antigen |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Cornified envelope |
| Swissprot ID | O60437 |
| Reactive glutamines | Not determined yet |
| Reactive lysines | Not determined yet |
| Substrate sequence | |
| Structure | No available crystal structure |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:12923681 |
| Notes | It forms multimers upon TG2 action |
| Template:Infobox header | |
